The Effect of Acylcarnitines on Cognitive Function: A Two‐Sample Mendelian Randomization Study
Brain and Behavior · 2025
DOI: 10.1002/brb3.70646 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Behavior, 2025. Verfasst von Sisi Luan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Carnitine, Cognition. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Objective
Clinical trials investigating the association between acylcarnitines and cognitive function have yielded conflicting results. We conducted a Mendelian randomization (MR) study to examine the causal associations between 20 acylcarnitines and neurocognitive outcomes.
Methods
Single‐nucleotide polymorphisms of 20 acylcarnitines were extracted from primary European ancestry‐based genome‐wide association studies. Two‐sample MR (TSMR) was performed to initially screen for acylcarnitines potentially associated with cognitive performance. Further TSMR analysis was conducted to investigate the associations between specific acylcarnitines and other cognitive outcomes, dementia, and brain structure.
Results
Among the 20 acylcarnitines, we observed that lower genetically predicted levels of butyrylcarnitine ( β = −0.06, 95% CI: [−0.11 to −0.02], p = 0.003) and acetyl‐L‐carnitine ( β = −0.02, 95% CI: [−0.04 to 0], p = 0.04) were associated with adverse neurocognitive effects. Furthermore, we found a negative correlation between low genetically predicted levels of butyrylcarnitine and cognitive function ( β = −0.17, 95% CI: [−0.3 to −0.05], p = 0.01) as well as intelligence ( β = −0.05, 95% CI: [−0.09 to −0.02], p = 0.003). However, there was no evidence supporting any association between these two acylcarnitines and dementia or brain structure.
Conclusions
Our results suggest a causal association between acetyl‐L‐carnitine and butyrylcarnitine levels and adverse neurocognitive effects. Multicenter, multiregional, and large sample studies are needed to further validate these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
- Beijing Tongren Hospital, Capital Medical University, Beijing, China.
- Plastic Surgery Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
ORCID-Profile: Sisi Luan
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Luan, S., Zhang, J., Wang, C., Wang, Z., & Zhou, J. (2025). The Effect of Acylcarnitines on Cognitive Function: A Two‐Sample Mendelian Randomization Study. Brain and Behavior. https://doi.org/10.1002/brb3.70646
Vancouver
Luan S, Zhang J, Wang C, Wang Z, Zhou J. The Effect of Acylcarnitines on Cognitive Function: A Two‐Sample Mendelian Randomization Study. Brain and Behavior. 2025. doi:10.1002/brb3.70646
BibTeX
@article{Luan2025,
author = {Luan, Sisi and Zhang, Jinyan and Wang, Chenglong and Wang, Ziqi and Zhou, Jianbo},
title = {The Effect of Acylcarnitines on Cognitive Function: A Two‐Sample Mendelian Randomization Study},
journal = {Brain and Behavior},
year = {2025},
doi = {10.1002/brb3.70646}
}
EUVIMED